Related Experiment Video
Updated: Dec 24, 2025

Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
ResNet-SCDA-50 for Breast Abnormality Classification
Abstract:
(Aim) Breast cancer is the most common cancer in women and the second most common cancer worldwide. With the rapid advancement of deep learning, the early stages of breast cancer development can be accurately detected by radiologists with the help of artificial intelligence systems. (Method) Based on mammographic imaging, a mainstream clinical breast screening technique, we present a diagnostic system for accurate classification of breast abnormalities based on ResNet-50. To improve the proposed model, we created a new data augmentation framework called SCDA (Scaling and Contrast limited adaptive histogram equalization Data Augmentation). In its procedure, we first conduct the scaling operation to the original training set, followed by applying contrast limited adaptive histogram equalisation (CLAHE) to the scaled training set. By stacking the training set after SCDA with the original training set, we formed a new training set. The network trained by the augmented training set, was coined as ResNet-SCDA-50. Our system, which aims at a binary classification on mammographic images acquired from INbreast and MINI-MIAS, classifies masses, microcalcification as "abnormal", while normal regions are classified as "normal". (Results) We present the first attempt to use the image contrast enhancement method as the data augmentation method, resulting in an averaged 98.55 percent specificity and 92.83 percent sensitivity, which gives our best model an overall accuracy of 95.74 percent. (Conclusion) Our proposed method is effective in classifying breast abnormality.
More Related Videos
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
08:16X-ray Visualization of Intraductal Ethanol-based Ablative Infusion for Prevention of Breast Cancer in Rabbit Models
Published on: September 12, 2025